AI And Genomics Will Expand Screening For Aging Markets
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 23 Analysts
Published
23 Aug 25
Updated
23 Aug 25
AnalystHighTarget's Fair Value
US$78.20
41.6% undervalued intrinsic discount23 Aug
US$45.66
1Y
-23.7%7D
1.3%1Y
-23.7%7D
1.3%